T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOEBT1 who wrote (110)	5/5/2000 5:15:00 PM
From: nigel bates	of 2243

JOE, There is no mention of IMGN in the press releases, just BZL biovation.co.uk "Biovation Limited, the specialist protein engineering company, today announced an agreement with BZL Biologics of New York to further engineer BZL's antibody therapeutic for prostate cancer. BZL's antibody has previously been humanised using Biovation's proprietary DeImmunisation technology" (4thJan99) I posted details of their technology to the CAT thread. nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next